Atomera (ATOM) Q4 2024 earnings summary

Executive summary

• Advanced across all customer categories, entered new segments, and neared first production in 2024, including progress toward commercialization with ST Microelectronics and expanded gate-all-around offerings for advanced AI devices.

• Engaged with more than half of the world's top semiconductor makers, with 20 customers and 26 active engagements, and initiated new development efforts with two large customers.

• Strong support for MST technology at engineering levels, with significant engagement from major industry players and expanded offerings for next-generation AI devices.

• Expanded R&D pipeline and patent portfolio, with over 30 new patents granted or pending in 2024 and a total of 347 granted and pending patents.

• Focuses on MST transistor enhancement technology for the $600B semiconductor market, leveraging a high-margin IP licensing model.

Financial highlights

• Fiscal 2024 revenue was $135,000, primarily from MST CAD licensing and NRE fees, down from $550,000 in 2023.

• GAAP net loss for 2024 was $18.4 million ($0.68/share), improved from $19.8 million ($0.80/share) in 2023.

• Adjusted EBITDA loss for 2024 was $15.4 million, with a per-share loss of $0.57, improved from $16.6 million in 2023.

• Q4 2024 revenue was $23,000, with a GAAP net loss of $4.7 million ($0.16/share).

• Cash, cash equivalents, and short-term investments totaled $26.8 million at year-end 2024, up from $19.5 million in 2023.

Outlook and guidance

• No revenue expected in Q1 2025; potential NRE revenue from a fabless licensee may occur in Q1 or Q2.

• Next major revenue milestone tied to ST entering formal process qualification.

• 2025 non-GAAP OpEx expected to be $17–18 million, consistent with 2023 levels.

• MST technology targets multiple growth areas, including power, RF-SOI, advanced nodes, and DRAM, positioning for future semiconductor industry trends.

• Conservative approach to structural spending increases due to limited revenue visibility.